Across both patient cohorts, the high IL6R expression, poor outcome patients had significantly higher numbers of lymph node metastases (LN met) (cohort 1; p = 0.003, cohort 2; p = 0.035). Here, IL6R is linked to metastatic malignant neoplasm in the lymph nodes.